Dialysis firm sees positive revenue growth ahead

|By:, SA News Editor

Citing a growing patient pool and an expansion of offerings into kidney failure-related medical fields, Fresenius Medical Care (FMS +2.6%) forecasts its top line to double to $28B by 2020.

The number of global dialysis patients should grow 6.3%/year, slightly lower than the 6.8% rate over the past 13 years.

The company believes it is well-positioned to take advantage of the transition from payments for individual services to lump-sum payments per dialysis session.

(DVA +0.3%)